Literature DB >> 14620929

Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice.

Pei Niu1, Takayuki Shindo, Hiroshi Iwata, Aya Ebihara, Yoshihiro Suematsu, Yuelan Zhang, Norifumi Takeda, Satoshi Iimuro, Yasunobu Hirata, Ryozo Nagai.   

Abstract

Adrenomedullin (AM) is a potent vasodilating and natriuretic peptide that is thought to play important roles in cardiovascular function. Whether or not AM is involved in the development of cardiac hypertrophy and renal damage remains controversial. In the present study, using heterozygote knockout mice of the AM gene (AM +/-), we analyzed the physiological and pathological roles of the endogenous AM gene. There were no differences in body size or heart and kidney weight compared with wild-type (AM +/+) mice. However, angiotensin II (Ang II) infusion resulted in more severe cardiac hypertrophy in AM +/- mice. The increases in the heart weight-to-body weight ratio and wall thickness of the left ventricle were more prominent in the AM +/- mice. Renal dysfunction characterized by decreased creatinine clearance (C(cr)) was more severe in AM +/- after Ang II infusion. These results suggest that AM plays critical roles in the defense mechanism against cardiac hypertrophy and renal dysfunction. An improved understanding of these roles may pave the way to a novel pharmacological approach for the prevention of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620929     DOI: 10.1291/hypres.26.731

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  9 in total

1.  The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity.

Authors:  Yuka Ichikawa-Shindo; Takayuki Sakurai; Akiko Kamiyoshi; Hisaka Kawate; Nobuyoshi Iinuma; Takahiro Yoshizawa; Teruhide Koyama; Junichi Fukuchi; Satoshi Iimuro; Nobuo Moriyama; Hayato Kawakami; Toshinori Murata; Kenji Kangawa; Ryozo Nagai; Takayuki Shindo
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

2.  Adrenomedullin Improves Cardiac Remodeling and Function in Obese Rats with Hypertension.

Authors:  Pei Qian; Qian Wang; Fang-Zheng Wang; Hang-Bing Dai; Hong-Yu Wang; Qing Gao; Hong Zhou; Ye-Bo Zhou
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-06

3.  Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene.

Authors:  Ryan T Dackor; Kimberly Fritz-Six; William P Dunworth; Carrie L Gibbons; Oliver Smithies; Kathleen M Caron
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

4.  Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males.

Authors:  Kathleen Caron; John Hagaman; Toshio Nishikimi; Hyung-Suk Kim; Oliver Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

5.  Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.

Authors:  Satoko Hayakawa; Koji Ohashi; Rei Shibata; Yoshiyuki Kataoka; Megumi Miyabe; Takashi Enomoto; Yusuke Joki; Yuuki Shimizu; Takahiro Kambara; Yusuke Uemura; Daisuke Yuasa; Hayato Ogawa; Kazuhiro Matsuo; Mizuho Hiramatsu-Ito; Maurice J B van den Hoff; Kenneth Walsh; Toyoaki Murohara; Noriyuki Ouchi
Journal:  J Am Soc Nephrol       Date:  2014-07-28       Impact factor: 10.121

Review 6.  Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.

Authors:  Christopher Geven; Matthijs Kox; Peter Pickkers
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 7.  Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases.

Authors:  Toshihiro Kita; Kazuo Kitamura
Journal:  Hypertens Res       Date:  2022-01-06       Impact factor: 5.528

8.  Plasma Clearance of Intravenously Infused Adrenomedullin in Rats with Acute Renal Failure.

Authors:  Hiroshi Hosoda; Tsutomu Nakamura; Fumiki Yoshihara
Journal:  Biomolecules       Date:  2022-09-11

9.  Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally Induced Cardiorenal Syndrome.

Authors:  Hani N Sabbah; Kefei Zhang; Ramesh C Gupta; Jiang Xu; Vinita Singh-Gupta
Journal:  J Card Fail       Date:  2020-08-22       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.